Dashboard
Manage Tickers

CICigna Group

NYSE cigna.com


$ 333.49 $ 3.58 (1.09 %)    

Thursday, 11-Jul-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 492.14 $ -11.98 (-2.38 %)
DIA $ 397.90 $ 0.34 (0.09 %)
SPY $ 556.42 $ -4.90 (-0.87 %)
TLT $ 93.53 $ 0.89 (0.96 %)
GLD $ 223.19 $ 3.83 (1.75 %)
$ 329.91
$ 327.48
$ 0.00 x 0
$ 0.00 x 0
$ 327.16 - $ 333.86
$ 251.86 - $ 364.21
1,981,992
na
93.72B
$ 0.90
$ 25.89
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

is-big-pharma-poised-to-take-over-cannabis-3-companies-already-manage-8-in-10-drug-prescriptions-in-the-us
Is Big Pharma Poised To Take Over Cannabis...
07/11/2024 19:01:01

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on d...

Core News & Articles
'FTC to Sue Drug Managers over Insulin Pri...
07/10/2024 17:52:27

The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating...

cantor-fitzgerald-reiterates-overweight-on-cigna-group-maintains-400-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/10/2024 14:52:39

Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $400 price target.

if-you-invested-100-in-this-stock-15-years-ago-you-would-have-1400-today
If You Invested $100 In This Stock 15 Year...
07/10/2024 14:00:42

ftc-investigation-uncovers-anti-competitive-practices-by-handful-of-pharmacy-benefit-managers-including-cvs-health-unitedhealth
FTC Investigation Uncovers Anti-Competitiv...
07/09/2024 17:46:01

The FTC's report reveals how major PBMs like UnitedHealth, CVS, and Cigna influence drug prices, impacting small pharmacies...

looking-into-cigna-groups-recent-short-interest
Looking Into Cigna Group's Recent Short In...
07/08/2024 17:30:14

decoding-cigna-groups-options-activity-whats-the-big-picture
Decoding Cigna Group's Options Activity: W...
07/05/2024 16:01:29

cignas-specialty-pharmacy-leadership-expected-to-drive-long-term-eps-growth-analyst-says
Cigna's Specialty Pharmacy Leadership Expe...
06/26/2024 18:40:22

Piper Sandler has initiated coverage on Cigna, highlighting its strong position in the specialty pharmacy market and robust gro...

what-analysts-are-saying-about-cigna-group-stock
What Analysts Are Saying About Cigna Group...
06/26/2024 12:01:39

piper-sandler-initiates-coverage-on-cigna-group-with-overweight-rating-announces-price-target-of-400
Piper Sandler Initiates Coverage On Cigna ...
06/26/2024 10:04:48

Piper Sandler analyst Jessica Tassan initiates coverage on Cigna Group (NYSE:CI) with a Overweight rating and announces Pric...

heres-how-much-1000-invested-in-cigna-group-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Cigna Gr...
06/21/2024 21:00:56

Core News & Articles
'House panel weighs new plan for Medicare ...
06/21/2024 18:42:14

https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/

Core News & Articles
Medicare Star Rankings Revision Could Resu...
06/13/2024 18:53:18

https://www.wsj.com/health/healthcare/medicare-will-recalculate-quality-ratings-of-medicare-advantage-plans-eebee409?mod=latest...

cantor-fitzgerald-reiterates-overweight-on-cigna-group-maintains-400-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/12/2024 16:22:41

Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $400 price target.

cigna-cfo-says-pre-pandemic-norms-had-more-seasonality-in-medical-care-ratio-and-thats-more-of-what-cos-expects-this-year
Cigna CFO Says Pre Pandemic Norms Had More...
06/11/2024 14:42:07

- Goldman Sachs Conf

cigna-cfo-says-over-the-next-decade-we-see-a-wave-of-drug-innovation-transpiring
Cigna CFO Says Over The Next Decade, We Se...
06/11/2024 14:21:57

- Goldman Sachs Conf

Core News & Articles
Cigna CFO Says Cumulative Effect Of Elevat...
06/11/2024 14:20:21

- Goldman Sachs Conf

cigna-cfo-says-co-expects-the-select-segment-to-be-where-it-gets-the-outsized-growth-in-the-cigna-healthcare-portfolio
Cigna CFO Says Co Expects The Select Segme...
06/11/2024 14:15:32

- Goldman Sachs Conf

cigna-cfo-says-co-expects-that-it-will-continue-to-see-elevated-inpatient-activity-throughout-the-entire-2024-calendar-year-outpatient-dynamic-was-impacted-by-change-healthcare-hacks-disruption-of-claims-in-q1
Cigna CFO Says Co Expects That It Will Con...
06/11/2024 14:10:35

- Goldman Sachs Conf

cigna-cfo-says-we-are-seeing-elevated-cost-trends-across-the-portfolio-but-in-line-with-what-we-had-priced-and-expected
Cigna CFO Says We Are Seeing Elevated Cost...
06/11/2024 14:06:48

- Goldman Sachs Conf

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)